Meyers James R bought CTMX
June 17, 2026 · Form 4 insider transaction
Meyers James R bought 59,000 shares of CytomX Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
59,000
Price
$0.00
Total value
N/A
InsiderMeyers James R
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 17, 2026
Filing dateJune 22, 2026
Shares owned after59,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
100% of the shares subject to the option shall vest in full on the earlier of (i) the first anniversary of the grant date or (ii) the date of the 2027 Annual Meeting of the Issuer's stockholders, assuming continuous service as a director until such vesting date.